Drug Approval | April 17, 2026
Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The national platform brought together healthcare professionals, patient advocates, and stakeholders
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
Subscribe To Our Newsletter & Stay Updated
